Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi‐institution analysis

Sixteen medical institutions in Japan collaborated in this study of the epidemiology of hepatitis C virus (HCV) genotypes. A total of 4176 patients with type C chronic liver disease, from the four main islands of Japan, were evaluated. Of those evaluated, 2794 had chronic hepatitis, 727 had liver cirrhosis and 655 had hepatocellular carcinoma. The HCV genotype of the patients was determined by an enzyme‐linked immunosorbent assay based on serological genotype 1‐ and 2‐specific recombinant peptides (SG‐1 and SG‐2, respectively) of the NS4 region. The prevalence of SG‐1 and SG‐2 HCV was similar in the four main islands of Japan. SG‐1 HCV predominated in each disease category (69–76%). The percentage of patients with SG‐1 HCV increased by 7%, while that of patients with SG‐2 HCV decreased by 7%, as liver disease progressed in severity from chronic hepatitis to carcinoma (P < 0.001). Patients with either SG‐1 or SG‐2 had a similar mean age and history of blood transfusion. In conclusion, SG‐1 HCV was found to predominate in Japan, and the HCV genotype was found to be related to the stage of hepatitis C disease.

[1]  S. Mishiro,et al.  Transmission of Hepatitis C Virus From Mothers to Infants , 1994 .

[2]  S. Yagi,et al.  Significance of specific antibody assay for genotyping of hepatitis C virus , 1994, Hepatology.

[3]  E. Holmes,et al.  A proposed system for the nomenclature of hepatitis C viral genotypes , 1994, Hepatology.

[4]  S Sherlock,et al.  Hepatitis C virus genotypes: An investigation of type‐specific differences in geographic origin and disease , 1994, Hepatology.

[5]  P. Simmonds,et al.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.

[6]  J. Chiba,et al.  Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long‐term follow‐up , 1993, Journal of medical virology.

[7]  K. Chayama,et al.  Genotypic subtyping of hepatitis C virus , 1993, Journal of gastroenterology and hepatology.

[8]  E. Holmes,et al.  Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. , 1993, The Journal of general virology.

[9]  S. Gaiani,et al.  Persistent hepatitis C viraemia without liver disease , 1993, The Lancet.

[10]  A. Nomoto,et al.  Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis. , 1993, Virology.

[11]  P. Simmonds,et al.  Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities , 1993, Transfusion.

[12]  Motohiro Shibata,et al.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: Relationship to genotypes of hepatitis C virus , 1992, Hepatology.

[13]  B. Irvine,et al.  At least five related, but distinct, hepatitis C viral genotypes exist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Mishiro,et al.  Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. , 1992, Virology.

[15]  E. Holmes,et al.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. , 1992, The Journal of general virology.

[16]  H. Okamoto,et al.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. , 1992, The Journal of general virology.

[17]  N. Kato,et al.  A new type of hepatitis C virus in patients in Thailand. , 1992, Biochemical and biophysical research communications.

[18]  Q. Choo,et al.  Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan. , 2008, Liver.

[19]  S. Zebedee,et al.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Trépo,et al.  Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. , 1991, Gene.

[21]  N Enomoto,et al.  Typing of hepatitis C virus genomes by restriction fragment length polymorphism. , 1991, The Journal of general virology.

[22]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[23]  M. Houghton,et al.  Analysis of genomic variability of hepatitis C virus. , 1991, Journal of hepatology.

[24]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[25]  N. Enomoto,et al.  There are two major types of hepatitis C virus in Japan. , 1990, Biochemical and biophysical research communications.

[26]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[27]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[28]  S. Kurashina,et al.  South-to-north gradient in distribution of the r determinant of hepatitis B surface antigen in Japan. , 1975, The Journal of infectious diseases.

[29]  W. Bancroft,et al.  Detection of additional antigenic determinants of hepatitis B antigen. , 1972, Journal of immunology.

[30]  G. Bouvier.  The heterogeneity of Australia antigen. , 1971 .

[31]  G. L. Le Bouvier.  The heterogeneity of Australia antigen. , 1971, The Journal of infectious diseases.